TNM Classification of Thyroid Carcinoma

@article{Shaha2007TNMCO,
  title={TNM Classification of Thyroid Carcinoma},
  author={Ashok R. Shaha},
  journal={World Journal of Surgery},
  year={2007},
  volume={31},
  pages={879-887}
}
  • A. Shaha
  • Published 1 February 2007
  • Medicine, Biology
  • World Journal of Surgery
BackgroundThe understanding of biology of well-differentiated thyroid cancer has improved in the last two decades with the detailed understanding of prognostic factors and risk group stratification. The risk groups are crucial in the management of thyroid cancer and overall prognosis.TNM Staging SystemThe TNM staging system has been used in all human cancers, and it adheres to the biology of tumors. The data in thyroid cancer comes from retrospective studies, as there are no prospective… 
Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
TLDR
It is suggested that no one staging system has been shown to be superior to another across different patient populations with DTC, and additional factors, such as biological markers, added to the clinical and pathological characteristics may lead to the development of superior staging systems.
Staging Systems for Differentiated Thyroid Carcinomas
TLDR
The goal of each staging system is to provide a more precise depiction of the tumor to aid the physician in the selection of the best course of treatment for the patient, and to assist in the prediction of disease-specific mortality.
Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines
TLDR
Survival of patients with well-differentiated thyroid cancer was adversely affected by lymph node metastases, and prophylactic central LN dissection did improve accuracy in staging and decrease postop TG level, but it had no effect on small-sized tumors.
Simplifying the TNM system for clinical use in differentiated thyroid cancer.
TLDR
The QTNM system as opposed to the conventional TNM system seems to be a simple and effective method for risk stratification for both recurrence and cancer-specific mortality.
Clinicopathologic and molecular disease prognostication for papillary thyroid cancer
TLDR
The parameters used most commonly to differentiate low-risk PTCs from their more aggressive variants are reviewed and some of the newest molecular therapies for this latter group of tumors are described.
Recommendation for Subclass Evaluation of TNM stage IVA Papillary Thyroid Carcinomas: T4aN1b Patients Are at Risk for Recurrence and Survival
TLDR
In multivariate analysis, esophageal invasion and lymphadenopathy were independent risk factors for both DFS and DSS in stage IVA PTC patients, and patients with T4aN1b are at greater risk for worse prognosis.
Thyroid cancer in young adults.
TLDR
The prognosis for the most common thyroid malignancy, papillary thyroid carcinoma (PTC), is excellent and the treatment of young adult thyroid cancer patients occurs optimally as part of a multidisciplinary coordination of care.
[Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].
TLDR
This research has shown that lymphocytes in tissue as part of Hashimoto thzroiditis have an effect on certain prognostic factors of differentiated thyroid carcinoma as size, smaller invasiveness and extrathyroid tumour growth and incidence of hematogenic metastases.
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
TLDR
It is recommended that TNM be replaced with QTNM for risk stratification for both recurrence and CSS, and its advantage in clearly discriminating between prognostic groups, clinical relevance and simplicity of use is recommended.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Low-risk differentiated thyroid cancer: The need for selective treatment
TLDR
Patients with low-risk tumors have excellent long-term survival and should be avoided, and intraoperative decisions regarding the extent of thyroidectomy should be based on gross clinical findings and risk group analysis.
TNM: evolution and relation to other prognostic factors.
  • L. Sobin
  • Medicine
    Seminars in surgical oncology
  • 2003
TLDR
The TNM Classification describes the anatomic extent of cancer and provides an inviting foundation upon which to build a prognostic classification; however, this carries a risk that the system will be overwhelmed by a variety of prognostic data.
Staging in thyroid carcinoma
TLDR
The authors state that the goals of this prospective multicenterregistry were to establish a broadly applicable staging class to predict patient outcome, establish contemporary clinical practice in themanagement of disease in these patients, and determine the effec-tion of the staging system.
An expanded view of risk-group definition in differentiated thyroid carcinoma.
TLDR
This work offers here another multifactorial system for the identification of low-risk patients who made up 89.4% of all patient seen between 1961 and 1980 and who have a death rate of only 1.8%.
Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma
TLDR
A multivariate analysis of the prognostic factors was carried out on a series of differentiated thyroid cancers followed for 8 to 40 years, finding that patients treated after 1960 have a better outcome than patients treated earlier, although they did not differ in age distribution, histologic characteristics, sex ratio, or incidence of palpable lymph nodes.
Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
TLDR
It is concluded that histologic subclassification may be less useful in estimating the prognosis in patients with differentiated thyroid carcinoma than other factors such as sex and the extent of the tumor.
...
1
2
3
4
...